Bayer Shoulders Marketing Spend To Lift Consumer Product Sales
Executive Summary
Headwinds for the consumer products business included support for launching ClariSpray and promoting the July introduction of Aleve Direct Therapy device for lower back pain.
You may also be interested in...
Coppertone, One-A-Day Sales Slump As Bayer’s Consumer Health Slide Continues
Bayer reported consumer health sales globally fell 1.4% to $1.64bn after a late start to the allergy season drove down Claritin sales. Aleve analgesics sales grew 3.3% to $112.5m on US line extensions while Alka Seltzer line sales were flat at $47.5m.
Bayer’s Consumer Health Sales Stay Cool During Summer Months
Bayer reported consumer health sales globally fell 1.4% to $1.64bn after a late start to the allergy season drove down Claritin sales. Aleve analgesics sales grew 3.3% to $112.5m on US line extensions while Alka Seltzer line sales were flat at $47.5m.
Bayer’s Consumer Health Sales Stay Cool During Summer Months
Bayer reported consumer health sales globally fell 1.4% to $1.64bn after a late start to the allergy season drove down Claritin sales. Aleve analgesics sales grew 3.3% to $112.5m on US line extensions while Alka Seltzer line sales were flat at $47.5m.